相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adeno-Associated Virus (AAV) Versus Immune Response
Joseph Rabinowitz et al.
VIRUSES-BASEL (2019)
AAV5-miHTT Gene Therapy Demonstrates Sustained Huntingtin Lowering and Functional Improvement in Huntington Disease Mouse Models
Elisabeth A. Spronck et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors
Anita Kruzik et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
AAV gene delivery to the spinal cord: serotypes, methods, candidate diseases, and clinical trials
Nathan Hardcastle et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2018)
Inflammation in CNS neurodegenerative diseases
Jodie Stephenson et al.
IMMUNOLOGY (2018)
Best practices for the use of intracerebroventricular drug delivery devices
Irene Slavc et al.
MOLECULAR GENETICS AND METABOLISM (2018)
The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice
Juliette Hordeaux et al.
MOLECULAR THERAPY (2018)
Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction
Zachary Fitzpatrick et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Iduronate-2-Sulfatase in Rhesus Macaques
Juliette Hordeaux et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Human Alpha-L-Iduronidase in Rhesus Macaques
Juliette Hordeaux et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
In vivo Imaging of Glial Activation in Alzheimer's Disease
Paul Edison et al.
FRONTIERS IN NEUROLOGY (2018)
Impact of AAV Capsid-Specific T-Cell Responses on Design and Outcome of Clinical Gene Transfer Trials with Recombinant Adeno-Associated Viral Vectors: An Evolving Controversy
Hildegund C. J. Ertl et al.
HUMAN GENE THERAPY (2017)
Direct Intracranial Injection of AAVrh8 Encoding Monkey β-N-Acetylhexosaminidase Causes Neurotoxicity in the Primate Brain
Diane Golebiowski et al.
HUMAN GENE THERAPY (2017)
Clinical Gene Therapy for Neurodegenerative Diseases: Past, Present, and Future
Francoise Piguet et al.
HUMAN GENE THERAPY (2017)
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
J. R. Mendell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Intracerebroventricular Delivery as a Safe, Long-Term Route of Drug Administration
Jessica L. Cohen-Pfeffer et al.
PEDIATRIC NEUROLOGY (2017)
Overcoming the Host Immune Response to Adeno-Associated Virus Gene Delivery Vectors: The Race Between Clearance, Tolerance, Neutralization, and Escape
Federico Mingozzi et al.
ANNUAL REVIEW OF VIROLOGY, VOL 4 (2017)
Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV-hGAA) Gene Therapy in Children Affected by Pompe Disease
Manuela Corti et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2017)
Development of a Novel AAV Gene Therapy Cassette with Improved Safety Features and Efficacy in a Mouse Model of Rett Syndrome
Kamal K. E. Gadalla et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
Benjamin E. Deverman et al.
NATURE BIOTECHNOLOGY (2016)
How neuroinflammation contributes to neurodegeneration
Richard M. Ransohoff
SCIENCE (2016)
Safety Evaluation of CNS Administered Biologics-Study Design, Data Interpretation, and Translation to the Clinic
Brian R. Vuillemenot et al.
TOXICOLOGICAL SCIENCES (2016)
Cerebellomedullary Cistern Delivery for AAV-Based Gene Therapy: A Technical Note for Nonhuman Primates
Lluis Samaranch et al.
HUMAN GENE THERAPY METHODS (2016)
Targeted approaches to induce immune tolerance for Pompe disease therapy
Phillip A. Doerfler et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Manufacturing of recombinant adeno-associated viral vectors for clinical trials
Nathalie Clement et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Microglia-specific targeting by novel capsid- modified AAV6 vectors
Awilda M. Rosario et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Rapamycin increases neuronal survival, reduces inflammation and astrocyte proliferation after spinal cord injury
Yona Goldshmit et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2015)
Widespread and Efficient Transduction of Spinal Cord and Brain Following Neonatal AAV Injection and Potential Disease Modifying Effect in ALS Mice
Jacob I. Ayers et al.
MOLECULAR THERAPY (2015)
Improving Single Injection CSF Delivery of AAV9-mediated Gene Therapy for SMA: A Dose-response Study in Mice and Nonhuman Primates
Kathrin Meyer et al.
MOLECULAR THERAPY (2015)
Neuroinflammation: Ways in Which the Immune System Affects the Brain
Richard M. Ransohoff et al.
NEUROTHERAPEUTICS (2015)
Biochemical, histological and functional correction of mucopolysaccharidosis Type IIIB by intra-cerebrospinal fluid gene therapy
Albert Ribera et al.
HUMAN MOLECULAR GENETICS (2015)
3′UTRs take a long shot in the brain
Li Wang et al.
BIOESSAYS (2014)
Transduction efficiency of neurons and glial cells by AAV-1,-5,-9,-rh10 and-hu11 serotypes in rat spinal cord following contusion injury
H. A. Petrosyan et al.
GENE THERAPY (2014)
Immune Responses to Intramuscular Administration of Alipogene Tiparvovec (AAV1-LPLS447X) in a Phase II Clinical Trial of Lipoprotein Lipase Deficiency Gene Therapy
Valerie Ferreira et al.
HUMAN GENE THERAPY (2014)
Plasmapheresis Eliminates the Negative Impact of AAV Antibodies on Microdystrophin Gene Expression Following Vascular Delivery
L. G. Chicoine et al.
MOLECULAR THERAPY (2014)
Intrathecal Gene Therapy Corrects CNS Pathology in a Feline Model of Mucopolysaccharidosis I
Christian Hinderer et al.
MOLECULAR THERAPY (2014)
Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia
Morgane Perdomini et al.
NATURE MEDICINE (2014)
Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse
Daniel J. Schuster et al.
FRONTIERS IN NEUROANATOMY (2014)
Biology of adeno-associated viral vectors in the central nervous system
Giridhar Murlidharan et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
Toll-like receptor signaling pathways
Takumi Kawasaki et al.
FRONTIERS IN IMMUNOLOGY (2014)
Feasibility and Safety of Systemic rAAV9-hNAGLU Delivery for Treating Mucopolysaccharidosis IIIB: Toxicology, Biodistribution, and Immunological Assessments in Primates
Darren A. Murrey et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2014)
Current perspectives on intrathecal drug delivery
Michael M. Bottros et al.
JOURNAL OF PAIN RESEARCH (2014)
B-cell depletion is protective against anti-AAV capsid immune response: a human subject case study
M. Corti et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2014)
Widespread gene transfer in the central nervous system of cynomolgus macaques following delivery of AAV9 into the cisterna magna
Christian Hinderer et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2014)
Immune responses to AAV vectors: overcoming barriers to successful gene therapy
Federico Mingozzi et al.
BLOOD (2013)
Immunologic privilege in the central nervous system and the blood-brain barrier
Leslie L. Muldoon et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
CpG-depleted adeno-associated virus vectors evade immune detection
Susan M. Faust et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
B-Cell Depletion and Immunomodulation before Initiation of Enzyme Replacement Therapy Blocks the Immune Response to Acid Alpha-Glucosidase in Infantile-Onset Pompe Disease
Melissa E. Elder et al.
JOURNAL OF PEDIATRICS (2013)
Capsid Serotype and Timing of Injection Determines AAV Transduction in the Neonatal Mice Brain
Paramita Chakrabarty et al.
PLOS ONE (2013)
Enlargement of Cerebral Ventricles as an Early Indicator of Encephalomyelitis
Stefano Lepore et al.
PLOS ONE (2013)
The role of markers of inflammation in traumatic brain injury
Thomas Woodcock et al.
FRONTIERS IN NEUROLOGY (2013)
Decreased carbon-11-flumazenil binding in early Alzheimer's disease
Belen Pascual et al.
BRAIN (2012)
Adeno-Associated Virus Serotype 9 Transduction in the Central Nervous System of Nonhuman Primates
Lluis Samaranch et al.
HUMAN GENE THERAPY (2012)
Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
Gabriele Mittermeyer et al.
HUMAN GENE THERAPY (2012)
Innate immunity in the central nervous system
Richard M. Ransohoff et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Cerebrospinal fluid and lumbar puncture: a practical review
Ben L. C. Wright et al.
JOURNAL OF NEUROLOGY (2012)
Proteasome Inhibition Is Partially Effective in Attenuating Pre-Existing Immunity against Recombinant Adeno-Associated Viral Vectors
Jozsef Karman et al.
PLOS ONE (2012)
TLR7 and TLR9 Trigger Distinct Neuroinflammatory Responses in the CNS
Niranjan B. Butchi et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver
Ashley T. Martino et al.
BLOOD (2011)
Optimizing Promoters for Recombinant Adeno-Associated Virus-Mediated Gene Expression in the Peripheral and Central Nervous System Using Self-Complementary Vectors
Steven J. Gray et al.
HUMAN GENE THERAPY (2011)
Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates
Steven J. Gray et al.
MOLECULAR THERAPY (2011)
A 10 Patient Case Report on the Impact of Plasmapheresis Upon Neutralizing Factors Against Adeno-associated Virus (AAV) Types 1, 2, 6, and 8
Virginie Monteilhet et al.
MOLECULAR THERAPY (2011)
Safe, Efficient, and Reproducible Gene Therapy of the Brain in the Dog Models of Sanfilippo and Hurler Syndromes
N. Matthew Ellinwood et al.
MOLECULAR THERAPY (2011)
Correction of Neurological Disease of Mucopolysaccharidosis IIIB in Adult Mice by rAAV9 Trans-Blood-Brain Barrier Gene Delivery
Haiyan Fu et al.
MOLECULAR THERAPY (2011)
The myeloid cells of the central nervous system parenchyma
Richard M. Ransohoff et al.
NATURE (2010)
Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2010)
The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice
Jiangao Zhu et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons
Sandra Duque et al.
MOLECULAR THERAPY (2009)
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2009)
TLR2 and TLR9 Synergistically Control Herpes Simplex Virus Infection in the Brain
Louise N. Sorensen et al.
JOURNAL OF IMMUNOLOGY (2008)
The blood-brain barrier in health and chronic neurodegenerative disorders
Berislav V. Zlokovic
NEURON (2008)
Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: The role of immunological synapses in understanding the cell biology of neuroimmune interactions
Pedro R. Lowenstein et al.
CURRENT GENE THERAPY (2007)
Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits
Sung-Chun Tang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Gene therapy of the brain in the dog model of Hurler's syndrome
Carine Ciron et al.
ANNALS OF NEUROLOGY (2006)
Immune responses to AAV in a phase I study for Canavan disease
S. W. J. McPhee et al.
JOURNAL OF GENE MEDICINE (2006)
Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response
CS Manno et al.
NATURE MEDICINE (2006)
Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain
CN Cearley et al.
MOLECULAR THERAPY (2006)
LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide
Y Liu et al.
BRAIN (2005)
Polyclonal rabbit antithymocyte globulin triggers B-Cell and plasma cell apoptosis by multiple pathways
MS Zand et al.
TRANSPLANTATION (2005)
Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs
JK Olson et al.
JOURNAL OF IMMUNOLOGY (2004)
Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain
CS Peden et al.
JOURNAL OF VIROLOGY (2004)
Autologous stem cell transplantation for systemic lupus erythematosus
D Jayne et al.
LUPUS (2004)
Cultured astrocytes express toll-like receptors for bacterial products
CC Bowman et al.
GLIA (2003)
Broad expression of Toll-like receptors in the human central nervous system
M Bsibsi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
GP Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
分享论文
